T. Hong

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer.

A. Zhu, D. Ryan, E. Kwak, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer—a Large Single-Center Experience

D. Berger, Jill N. Allen, L. Blaszkowsky, 2017, Journal of Gastrointestinal Surgery.

NRG/RTOG 1112: Randomized Phase III Study of Sorafenib vs. Stereotactic Body Radiation Therapy (SBRT) Followed by Sorafenib in Hepatocellular Carcinoma (HCC) (NCT01730937)

L. Dawson, A. Zhu, E. Koay, 2022, International Journal of Radiation Oncology*Biology*Physics.

Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.

R. Mak, N. Choi, C. Willett, 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.

P. Catalano, R. Bueno, P. Enzinger, 2017, Diseases of the esophagus.

Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

Issam El Naqa, Prajnan Das, Aditya Apte, 2009, International journal of radiation oncology, biology, physics.